Gene Transfer for Intractable Pain: A Phase I
Clinical Trial to Determine the Maximum Tolerable
Dose of a Replication Defective HSV Vector
Expressing Human Proenkephalin
Clinical Trial to Determine the Maximum Tolerable
Dose of a Replication Defective HSV Vector
Expressing Human Proenkephalin
David Fink, M.D.
Joseph Glorioso, Ph.D.
Joseph Glorioso, Ph.D.
Neal DeLuca, Ph.D.
Gurkamal Chatta, M.D.
Doris Cope, M.D.
Nashaat Rizk, M.D.
Thomas Rudy, Ph.D.
Principal
Investigators:
Co-Investigators: